This MedLibrary.org supplementary page on Numico is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
| Type | Wholly-owned subsidiary |
|---|---|
| Founded | 1896 |
| Headquarters | Amsterdam, the Netherlands |
| Key people | Jan Bennink, CEO |
| Industry | Food |
| Products | Baby food Clinical nutrition |
| Revenue | € 2.644 billion (2006) |
| Owner | Groupe Danone |
| Employees | 13,500 |
| Website | www.numico.com |
Numico (or in full Koninklijke Numico N.V., Royal Numico N.V.), is a specialist baby food and clinical nutrition subsidiary of Groupe Danone. Products range from infant milk formula to specialised nutrition for babies with specific needs and for breastfeeding mothers. It also produces and markets special clinical nutrition, diet products and disease-specific nutrition. Its main brands are Nutricia, Milupa, Mellin, Cow & Gate, and Dumex.
The name, "NUMICO", is formed by NUtricia, MIlupa, COw & Gate.
Numico has three divisions:
- Baby Food
- Clinical Nutrition
- Research & Development
The company's Dairy & Drinks division was sold to Friesland Coberco in March 2001, currently named Royal Friesland Foods. This division was well known for its brands Chocomel/Cécémel, Fristi, Nutroma and Extran which are all still in use by the new owner. This deal is part of Numico's strategy to concentrate on baby and clinical nutrition.
On 2007-07-09, a €12.3 billion offer for the company by French rival Danone was accepted by the Numico board.1 Danone announced ownership of over 90% of Numico's shares on 31 October 2007, declaring its offer for the remainder unconditional.2 As a result, Numico was removed from the AEX index. The company's shares were delisted from the Amsterdam Stock Exchange at the end of 2007 as Danone gained full control.3 On 28 October 2008, the Court of Appeals ruled that all remaining Numico shares were to be transferred to Danone (squeeze out) at the initial offer price of € 55 per share. At the time Danone held approximately 98.9% of the Numico shares.
References
- ^ "Danone to Offer 12.3 Billion Euros for Numico", CNBC (2007-07-09). Retrieved on 9 July 2007.
- ^ "Danone says Numico bid unconditional, holds 90.5 pct", Reuters (31 October 2007). Retrieved on 8 November 2007.
- ^ "Delisting of shares". Euronext (29 November 2007). Retrieved on 2008-02-19.
Wikipedia content modification information:
- This page was last modified on 27 November 2008, at 16:59.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Numico".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.